Molecular pharmacology of the sodium channel mutation D1790G linked to the long-QT syndrome

H. Abriel, X. H.T. Wehrens, J. Benhorin, B. Kerem, R. S. Kass*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

70 Scopus citations

Abstract

Background - Multiple mutations of SCN5A, the gene that encodes the human Na+ channel α-subunit, are linked to 1 form of the congenital long-QT syndrome (LQT-3). D1790G (DG), an LQT-3 mutation of the C-terminal region of the Na+ channel α-subunit, alters steady-state inactivation of expressed channels but does not promote sustained Na+ channel activity. Recently, flecainide, but not lidocaine, has been found to correct the disease phenotype, delayed ventricular repolarization, in DG carriers. Methods and Results - To understand the molecular basis of this difference, we studied both drugs using wild-type (WT) and mutant Na+ channels expressed in HEK 293 cells. The DG mutation conferred a higher sensitivity to lidocaine (EC50, WT=894 and DG=205 μmol/L) but not flecainide tonic block in a concentration range that is not clinically relevant. In contrast, in a concentration range that is therapeutically relevant, DG channels are blocked selectively by flecainide (EC50, WT= 11.0 and DG= 1.7 μmol/L), but not lidocaine (EC50, WT=318.0 and DG= 176 μmol/L) during repetitive stimulation. Conclusions - These results (1) demonstrate that the DG mutation confers a unique pharmacological response on expressed channels; (2) suggest that flecainide use-dependent block of DG channels underlies its therapeutic effects in carders of this gene mutation; and (3) suggest a role of the Na+ channel α-subunit C-terminus in the flecainide/channel interaction.

Original languageAmerican English
Pages (from-to)921-925
Number of pages5
JournalCirculation
Volume102
Issue number8
DOIs
StatePublished - 22 Aug 2000

Keywords

  • Antiarrhythmia agents
  • Electrophysiology
  • Genes
  • Ion channels
  • Pharmacology
  • Sodium

Fingerprint

Dive into the research topics of 'Molecular pharmacology of the sodium channel mutation D1790G linked to the long-QT syndrome'. Together they form a unique fingerprint.

Cite this